c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.
about
c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@en
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@nl
type
label
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@en
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@nl
prefLabel
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@en
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
c-Met, CREB1 and EGFR are invo ...... signaling in prostate cancer.
@en
P2093
Jiangfeng Li
Liping Xie
Mingjie Xu
Shuai Meng
P2860
P304
82303-82313
P356
10.18632/ONCOTARGET.19398
P407
P577
2017-07-19T00:00:00Z